Kaluza C Analysis Software
Purpose-built for clinical laboratories, Kaluza C Flow Cytometry Analysis Software helps you turn critical data into meaningful patient reports.
Receive your quote directly from the manufacturer.
With the power to processes multicolor files of up to 20 million events in real time, Kaluza C software streamlines quality control (QC) reporting requirements and enables you to analyze any flow cytometry standard (FCS) compliant file.
Features
- Listed with the FDA as a medical device
- Seamless integration with laboratory information systems (LIS)
- Powerful, real-time processing
- Compliant with FCS standard 3.1 or earlier
Medical device
Kaluza C software is listed with the FDA as a medical device and is also a CE-marked IVD product, ultimately helping to reduce your tool validation work.
Comprehensive compatibility
Compatible with listmode data files that are compliant with FCS standard 3.1 or earlier all from all acquisition software packages and cytometers.
Enhanced LIS integration
Kaluza C software provides integration with the LIS, which reduces the need for manual data entry and manual transcription.
Steps to standardize and streamline leukemia and lymphoma diagnostics
Discover the steps you can take to overcome the challenges of diagnosing leukemia and lymphoma using flow cytometric immunophenotyping (FCI) in this comprehensive eBook for clinical laboratory professionals.
Learn more about the current status of diagnostics for hematological malignancies and find information that will help support your journey to standardize your clinical flow cytometry workflow.
Download the free eBook for:
- An overview of current laboratory challenges and regulatory guidelines associated with laboratory-developed tests for flow cytometric workflows
- Practical steps that will help you standardize and streamline FCI for leukemia and lymphoma diagnostics
- Case studies on the advantages of validated assays
- A detailed guide to hematological malignancies and their specific markers including leukemias, lymphomas and myelomas
